The global ear nose throat (ENT) treatment market is projected to reach valuation US$ 26.29 Bn by 2029 and is estimated to expand at a CAGR of 6.3% from 2022 to 2030.
The global ear nose throat (ENT) treatment market is projected to reach valuation US$ 26.29 Bn by 2029 and is estimated to expand at a CAGR of 6.3% from 2022 to 2030
The increasing worldwide elderly population, as well as the increased incidence of various ear nose and throat ailments, are major growth drivers for the global ear, nose, and throat (ENT) treatment market. Products or devices in the global earnose and throat (ENT) treatment market are used for a variety of purposes, depending on the type of care provided to the patient. The global ear nose and throat (ENT) treatment market is expected to be driven by increasing stress on the healthcare industry to cut costs, substantial investments by governments and private sector players in the improvement of healthcare technologies and infrastructure, and favorable reimbursement regulations and laws in some new and existing nations in the coming years.
Download a FreeSample Copy with TOC@ https://www.precedenceresearch.com/sample/1534
| Report Scope | Details |
| Market Size in 2030 | USD 27.95 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 6.3% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Segments Covered | Devices, Drug Type, Organ Type, End User, Region |
Report Highlights
- On the basis of devices, hearing aid devices segment holds the largest market share in the global ear nose throat (ENT) treatment market. The factors such as technological developments, existence of key market players, and growing adoption of these kind of devices. In addition, the growing investments by market players is also driving the segment growth. According to the World Health Organization research from 2018, the number of people with hearing loss is anticipated to rise from 466 million in 2018 to over 900 million by 2050. As a result, demand for hearing aids will rise, bosting the segment growth.
- On the basis of end user, hospitals segment holds the largest market share in the global ear nose throat (ENT) treatment market. The hospitals visits have grown over the period of time. This factor is driving the growth of the segment.
Regional Snapshot
North America is the largest segment for ear nose throat (ENT) treatment market in terms of region.The U.S. is dominating the ear nose throat (ENT) treatment market in the North America region. The growth of ear nose throat (ENT) treatment market in North America region is being driven by the existence of major market players as well as the surge in demand for hearing gadgets and devices. In addition, adoption of latest and advanced technologies is also driving the growth of North America ear nose throat (ENT) treatment market.
Asia-Pacific region is the fastest growing region in the ear nose throat (ENT) treatment market.South Korea, Australia, and Thailandhold the highest market share in the Asia-Pacificear nose throat (ENT) treatment market. The ear nose throat (ENT) treatment market in Asia-Pacific region is expected to rise because of the technological developments and rise in healthcare expenditure in the region, and regulatory backing. Thus, the ear nose throat (ENT) treatment market in this region is expected to grow at a rapid pace.
Ask Here for Customization@ https://www.precedenceresearch.com/customization/1534
Market Dynamics
Drivers
Surge in demand for cosmetic ear nose throat (ENT) surgeries
According to American Society for Aesthetic Plastic Surgery, nearly 362,299 rhinoplasty surgeries were performed in the U.S. in 2019, with the figure dropping to 352,555 in 2020. In addition, technological developments are boosting the market growth. As a result, surge in demand for cosmetic ear nose throat (ENT) surgeries is driving the global ear nose throat (ENT) treatment market growth.
Restraints
Lack of skilled surgeons and otolaryngologists
The different countries all around the world are lacking skilled healthcare professionals. As per the pubmed.gov, in 2012, the U.S. had 8,600 otolaryngologists with a projected shortfall of 2,500 by 2050. Thus, lack of skilled surgeons and otolaryngologists are restricting the expansion of worldwide ear nose throat (ENT) treatment market.
Opportunities
Growing prevalence of ear nose throat (ENT) disorders
The growing prevalence of sinusitis is supporting the growth of global ear nose throat (ENT) treatment market. Chronic sinusitis affects roughly 12.1% of the elder population in the U.S., as per the Centers for Disease Control and Prevention. In India, chronic sinusitis affects 134 million individuals, as per the National Institute of Allergy and Infectious Diseases. Thus, growing prevalence of ear nose throat (ENT) disorders is contributing towards the growth of global ear nose throat (ENT) treatment market.
Challenges
High cost ofear nose throat (ENT) treatment as well as devices
The demand for ear nose throat (ENT) devices is falling due to growing cost of devices. Moreover, surgeon fees are quite high as compared to other doctors and healthcare practitioners. The sinus surgery costs from $1,900 to $2,800. As a result, high cost of ear nose throat (ENT) treatment as well as devices is the biggest challenge for the expansion of worldwide ear nose throat (ENT) treatment market.
Recent Developments
- Cochlear Limited and GN Hearing partnered with Google in September 2019 to declare assist for direct streaming from Android devices to hearing devices through Bluetooth Low Energy.
- WIDEX MOMENT, the first generation of hearing aids that sound natural, was introduced by WS Audiology in March 2020. Widex’s unique ZeroDelay Technology makes this possible.
Some of the key players in the market include:
- Novartis AG
- Pfizer Inc.
- GlaxoSmithKline Pharmaceuticals
- Teva Pharmaceuticals Industries Ltd.
- Sonova Holding AG
- Starkey Laboratories Inc.
- Siemens Healthcare
- Sonic Innovations Inc.
- American Hearing Systems Inc.
- Dr. Reddy’s Laboratories Ltd.
Market Segmentations:
By Devices
- Hearing Aid Devices
- Voice Prosthesis
- Nasal Splints
- Hearing Implants
- Endoscopes
- Others
By Drug Type
- Antibiotics
- Antihistamines
- Steroids
- Anti-inflammatory Drugs
- Others
By Organ Type
- Ear
- Nose
- Throat
By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Home Care Settings
- Others
Regional Segmentations:
- North America (U.S. and Canada)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Click Here to Browse Full Report Table of Contents
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Buy this Research Report@ https://www.precedenceresearch.com/checkout/1534
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333